414 related articles for article (PubMed ID: 9815624)
1. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
2. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
4. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
[TBL] [Abstract][Full Text] [Related]
5. Expression of p27kip1 in prostatic adenocarcinoma.
Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
Zheng XY; Ding W; Xie LP; Chen ZD
Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
[TBL] [Abstract][Full Text] [Related]
7. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
8. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
Revelos K; Petraki C; Gregorakis A; Scorilas A; Papanastasiou P; Tenta R; Koutsilieris M
In Vivo; 2005; 19(5):911-20. PubMed ID: 16097446
[TBL] [Abstract][Full Text] [Related]
9. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
11. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer.
Vis AN; van Rhijn BW; Noordzij MA; Schröder FH; van der Kwast TH
J Pathol; 2002 Jun; 197(2):148-54. PubMed ID: 12015737
[TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
13. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
Thomas GV; Schrage MI; Rosenfelt L; Kim JH; Salur G; deKernion JB; Dorey F; Said J; Reiter RE
J Urol; 2000 Dec; 164(6):1987-91. PubMed ID: 11061897
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
[TBL] [Abstract][Full Text] [Related]
15. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
Tsihlias J; Kapusta LR; DeBoer G; Morava-Protzner I; Zbieranowski I; Bhattacharya N; Catzavelos GC; Klotz LH; Slingerland JM
Cancer Res; 1998 Feb; 58(3):542-8. PubMed ID: 9458103
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
17. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
18. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of p27(Kip 1) cyclin-dependent kinase inhibitor in prostate cancer: distinct expression in various prostate cells associating with tumor stage and grades.
Nikoleishvili D; Pertia A; Tsintsadze O; Gogokhia N; Chkhotua A
Georgian Med News; 2007 Feb; (143):34-8. PubMed ID: 17404436
[TBL] [Abstract][Full Text] [Related]
20. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]